Growth factor signaling in metastasis: current understanding and future opportunities
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Growth factor signaling in metastasis: current understanding and future opportunities
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume 31, Issue 3-4, Pages 479-491
Publisher
Springer Nature
Online
2012-06-18
DOI
10.1007/s10555-012-9380-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-overexpression of Met and Hepatocyte Growth Factor Promotes Systemic Metastasis in NCI-H460 Non-Small Cell Lung Carcinoma Cells
- (2015) Roya Navab et al. NEOPLASIA
- Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation
- (2014) J Thompson Coon et al. HEALTH TECHNOLOGY ASSESSMENT
- Upcoming market catalysts in Q1 2012
- (2012) Edny Inui NATURE REVIEWS DRUG DISCOVERY
- MIR-99a and MIR-99b Modulate TGF-β Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells
- (2012) Gianluca Turcatel et al. PLoS One
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
- (2012) S. J. Conley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
- (2011) Nilay Sethi et al. CANCER CELL
- Chemotherapy Enhances Metastasis Formation via VEGFR-1-Expressing Endothelial Cells
- (2011) L. G. M. Daenen et al. CANCER RESEARCH
- miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer
- (2011) T. Tsuruta et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
- (2011) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Tumor Immune Escape Mechanisms that Operate During Metastasis
- (2011) D. O. Croci et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Breast Cancer-Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown
- (2011) S. Previdi et al. MOLECULAR CANCER THERAPEUTICS
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
- (2011) Michela Garofalo et al. NATURE MEDICINE
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation
- (2011) M Huang et al. ONCOGENE
- TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells
- (2011) S B Pakala et al. ONCOGENE
- Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
- (2011) Swati Biswas et al. PLoS One
- Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis
- (2011) E. S. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
- (2011) K. Yonesaka et al. Science Translational Medicine
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- The bone remodeling environment is a factor in breast cancer bone metastasis
- (2010) Li Laine Ooi et al. BONE
- TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1
- (2010) Anu Ganapathy et al. CANCER LETTERS
- TGF- Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
- (2010) R. W. Johnson et al. CANCER RESEARCH
- Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
- (2010) M. Cristofanilli et al. CLINICAL CANCER RESEARCH
- Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways
- (2010) Sara Previdi et al. EUROPEAN JOURNAL OF CANCER
- The dynamic roles of TGF-β in cancer
- (2010) Erik Meulmeester et al. JOURNAL OF PATHOLOGY
- Effect of the Specific Src Family Kinase Inhibitor Saracatinib on Osteolytic Lesions Using the PC-3 Bone Model
- (2010) J. C. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A compact VEGF signature associated with distant metastases and poor outcomes
- (2009) Zhiyuan Hu et al. BMC Medicine
- Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients
- (2009) Y H Park et al. BRITISH JOURNAL OF CANCER
- Transforming Growth Factor- 2 Is a Molecular Determinant for Site-Specific Melanoma Metastasis in the Brain
- (2009) C. Zhang et al. CANCER RESEARCH
- A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis
- (2009) K. Pedersen et al. MOLECULAR AND CELLULAR BIOLOGY
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
- (2009) Manav Korpal et al. NATURE MEDICINE
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells
- (2009) J Dai et al. ONCOGENE
- Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
- (2009) M Petersen et al. ONCOGENE
- RANKL inhibition in the treatment of bone metastases
- (2009) Allan Lipton et al. Current Opinion in Supportive and Palliative Care
- The Met tyrosine kinase receptor in development and cancer
- (2008) Alessandra Gentile et al. CANCER AND METASTASIS REVIEWS
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-β1
- (2008) Scott L. Kominsky et al. CLINICAL & EXPERIMENTAL METASTASIS
- Silencing of Transforming Growth Factor- 1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo
- (2008) L. D. Moore et al. CLINICAL CANCER RESEARCH
- Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
- (2008) Yoko Ueno et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan
- (2008) Toshimi Takano et al. JOURNAL OF CLINICAL ONCOLOGY
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
- Signaling networks assembled by oncogenic EGFR and c-Met
- (2008) A. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption
- (2008) Natalie A. Sims et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started